2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3342
  



  

  
Submitter : 
  

  
Mrs. Tricia Harrod
  

  
Date & Time: 
  

  
12/15/2006 08:12:48
  



  

  
Organization : 
  

  
Mrs. Tricia Harrod
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I am writing to ask you to issue guidelines to pharmacceutical companies that when manufacturing vaccines they restrict their use of stem cells to those lines established from sources other than fetal tissue obtained from aborted babies.

It only makes sense to utilize non-objectionable cell lines in vaccine production so that all people can benefit from them without compromising their moral beliefs and pro-life convictions.  This is especially true since there is an abundance of ethical sources.

Sincerely,

Tricia K Harrod

Aberdeen, SD